Jun 30, 2026 · 5 min
European stocks surge as AI demand and biotech breakthroughs shift capital
Abivax Soars, Siemens Energy Up, Mowi's Net Loss
Understanding these stock movements reveals how global themes like AI infrastructure and biotech safety trials are reshaping European equity portfolios.
- 1Abivax shares surged after clinical trials for its inflammatory bowel disease drug eased investor fears regarding cancer side effects.
- 2Siemens Energy is emerging as a key AI play in Europe by supplying the gas turbines required to power massive data centers.
- 3Salmon giant Mowi is struggling with net losses and stock declines following operational write-downs and industry oversupply.
Don't miss
The explanation of how Siemens Energy became an indirect proxy for the global artificial intelligence rally due to its data center power technology.
The brief
European equities are riding a massive wave, pacing toward their best quarter in nearly six years. Yet beneath the surface of this broad-based rally, individual stock movements reveal how specific corporate news and global trends are shifting investor capital.
Biotech firm Abivax saw its shares surge after positive clinical trials for an inflammatory bowel disease drug. Crucially, the data eased investor fears over potential cancer side effects, clearing a major hurdle for the experimental treatment.
Meanwhile, Europe's lack of direct tech giants has forced investors to get creative to gain exposure to the artificial intelligence boom. Many are piling into Siemens Energy, which supplies the essential gas turbines needed to power energy-hungry data centers.
In contrast to the tech-fueled optimism, salmon farming giant Mowi faced a steep decline. The company took a major write-down after selling part of its Canadian operations and slashed its harvest forecast due to industry headwinds like oversupply.
What was said on this episode
9 statements · 6 positive · 3 negative
Abivax could become a prime takeover target for large pharmaceutical companies
“it could be potentially a prime takeover target for some big pharmaceutical companies”
Listen at 1:46
Siemens Energy benefits from the AI rally through data-center gas-turbine demand
“Siemens Energy is one of those companies that is really benefiting from that because it provides gas turbines that are used to power data centers”
Listen at 2:26
Siemens Energy raised its outlook because gas-turbine demand and backlog are strong
“it recently raised its outlook because it's backlog for those gas turbines is massive and it has so much demand”
Listen at 2:36
Schneider Electric, ABB, and Prysmian benefit substantially from the AI boom
“companies like Schneider Electric or ABB or Prismian, all of those companies that are big beneficiaries of the AI boom”
Listen at 2:53
Siemens Energy could rise further if the AI-related rally continues
“Siemens Energy is up about 37% year to date. But it might have even further to go if that rally continues”
Listen at 3:20
Mowi is the world's largest salmon and trout farming company
“Maui is actually the world's largest company in salmon and trout farming”
Listen at 3:34
Mowi will record a write-down of about C$140 million
“it will have to take a write down of about 140 million Canadian dollars”
Listen at 3:46
New carbon regulations may increase salmon-farming costs
“new carbon regulations. That means a potential increase in costs going forward”
Listen at 4:13
Industry challenges may explain Mowi's 25% share-price decline this year
“that might explain that 25% drop in the shares for Maui this year”
Listen at 4:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Siemens Energy
Inflammatory bowel disease
Artificial IntelligenceListen to the full episode and explore every guest, topic, and moment on PodLume.